Filed: 11/14/2024ACC: 0000950123-24-011466
📋 What this filing means
ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $20.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$20.12M
Total AUM (reported)
1.59M
Total Shares
Allocation by class
COM$19.20M95.4%
CLASS A COM$924.1K4.6%
Portfolio Concentration
Top 3$20.12M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 1.59M
Sole
Full voting authority
1.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
CG ONCOLOGY INC
SOLEShares495.53K
TypeSH
Market value$18.70M
92.93%
Sole
495.53K
Shared
0.00
None
0.00
RAPID MICRO BIOSYSTEMS INC
SOLEShares1.04M
TypeSH
Market value$924.1K
4.59%
Sole
1.04M
Shared
0.00
None
0.00
PULMONX CORP
SOLEShares60.20K
TypeSH
Market value$499.1K
2.48%
Sole
60.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 495.53K | SH | $18.70M 92.93% | 495.53K | 0.00 | 0.00 |
RAPID MICRO BIOSYSTEMS INCSOLE | CLASS A COM | 1.04M | SH | $924.1K 4.59% | 1.04M | 0.00 | 0.00 |
PULMONX CORPSOLE | COM | 60.20K | SH | $499.1K 2.48% | 60.20K | 0.00 | 0.00 |